Sign in

The Canadian Cancer Trials Group

@cctg.bsky.social
161 followers 53 following 247 posts

The Canadian Cancer Trials Group (CCTG) is an academic cooperative oncology group that designs and conducts clinical trials testing cancer therapy, supportive care and prevention interventions across Canada.

PostsRepliesMedia
The Canadian Cancer Trials Group @cctg.bsky.social · 30/09/2026
Today is National Day for Truth and Reconciliation and Every Child Matters Orange Shirt Day. #CCTG is honouring Residential School Survivors, their families, and communities, and recognizes the lasting impacts of Canada’s Residential School system. #EveryChildMatters #TruthAndReconciliation
001
The Canadian Cancer Trials Group @cctg.bsky.social · 28/09/2026
CCTG poster presentations at #IMS26 in Glasgow, Scotland 🏴󠁧󠁢󠁳󠁣󠁴󠁿 ! Dr. Annette Hay with the TACtful Trial poster and Dr. Florenica Comelles presents the MY13 trials in progress abstract poster (Study Chair Dr. Hira Mian)
000
The Canadian Cancer Trials Group @cctg.bsky.social · 25/09/2026
Congratulations to Dr. Nizar Bahlis (U of Calgary) who is the 2026 recipient of the International Myeloma Society Anderson Award. A well deserved honour that reflects his impact on Myeloma care. #IMS26
011
The Canadian Cancer Trials Group @cctg.bsky.social · 24/09/2026
#CCTG MY13 study gets a shout out from the podium at #IMS26 during the session on optimal maintenance by Dr Pawlyn as a study asking key questions about current standards of care. @myelomasociety.org
001
The Canadian Cancer Trials Group @cctg.bsky.social · 24/09/2026
#CCTG is proud to be part of the The Marathon of Hope Cancer Centres Network working to unite Canadian researchers and improve the quality of life for cancer patients through precision oncology.
030
The Canadian Cancer Trials Group @cctg.bsky.social · 21/09/2026
The #CCTG PAC5 trial is now open to patient enrollment in Canada - to see if lanreotide can reduce the risk of postoperative pancreatic fistula (#POPF), one of the most important complications following #pancreatic cancer surgery. buff.ly/nDNpmIL
000
The Canadian Cancer Trials Group @cctg.bsky.social · 17/09/2026
#CCTG is seeking applications for a Breast Cancer Patient Representative - volunteer role supporting the Breast Disease Site Committee, and the Patient Representative Committee. Encouraging applications from New Brunswick, Nova Scotia, PEI or Newfoundland and Labrador. How to apply> buff.ly/anDXXyE
000
The Canadian Cancer Trials Group @cctg.bsky.social · 15/09/2026
Today is #WorldLymphomaDay and #CCTG is highlighting the IND245 clinical trial for people with mantle cell lymphoma receiving CAR-T therapy. The study is exploring whether two oral medications can improve outcomes and support patients through treatment. #WorldLymphomaDay #Lymphoma buff.ly/uEgVeey
000
The Canadian Cancer Trials Group @cctg.bsky.social · 14/09/2026
Tomorrow is #WorldLymphomaDay with a spotlight on the #CCTG IND244, clinical trial, for patients with primary central nervous system lymphoma evaluating a new treatment approach for patients who may not be able to receive intensive chemotherapy and stem cell transplantation. buff.ly/js35Jnd
010
The Canadian Cancer Trials Group @cctg.bsky.social · 08/09/2026
September is #ProstateCancerAwarenessMonth and the #CCTG PR.24 trial is comparing higher-dose radiation delivered over a shorter period of time compared to the current way radiation therapy is used to treat #ProstateCancer - #ClinicalTrials #BlueSeptember buff.ly/aBCMv1Z
000
The Canadian Cancer Trials Group @cctg.bsky.social · 04/09/2026
The #CCTG EN12 #RAINBO-ORANGE clinical trial has been funded through the #CIHR Project Grant - investigating surgery followed by radiotherapy and a type of oral endocrine therapy. www.ctg.queensu.ca/cctg_news/en...
022
The Canadian Cancer Trials Group @cctg.bsky.social · 02/09/2026
A new #CCTG clinical trial, ALC.8, is open for people with newly diagnosed, untreated high-risk acute myeloid leukemia (#AML). As part of #myeloMATCH, the study is comparing four treatment combinations with standard therapy. #ClinicalTrials #CancerResearch buff.ly/BVE1zY5
000
The Canadian Cancer Trials Group @cctg.bsky.social · 26/08/2026
#CCTG is seeking two new members for its Quality of Life Committee! Applicants with an interest or expertise in patient-reported outcomes are encouraged to apply, with roles focused on brain cancer and supportive care. Apply by August 31! #CancerResearch #PatientReportedOutcomes buff.ly/5UAqnCM
000
The Canadian Cancer Trials Group @cctg.bsky.social · 21/08/2026
Wrapping up the final day for #CCTG #NICTC2026 with Anna Johnson’s Health Equity talk, Michelle Audoin discussing Patient Engagement and concluding with an informative Industry Panel Discussion.
000
The Canadian Cancer Trials Group @cctg.bsky.social · 19/08/2026
#CCTG welcomes 60 new investigators to Day 1 of #NICTC2026 - a jam packed agenda covering the essentials of clinical trial conduct in the Canadian research environment.
010
Reposted by The Canadian Cancer Trials Group
Sinclair Cancer Research Institute @sinclaircri.bsky.social · 24/07/2026
INCREDIBLE — thank you #CIHR! 🎉 Huge congrats to all including our @sinclaircri.bsky.social team: Drs. Mueller, Abraham, Parulekar and Ethier (CBG, CCE & CCT), and Drs. Purzner, Talbot and Yang (associate members). BRAVO! @queensuhealth.bsky.social @cctg.bsky.social cihr-irsc.gc.ca/e/54787.html...
042
The Canadian Cancer Trials Group @cctg.bsky.social · 18/08/2026
#CCTG welcomes our 2026 #Practicum for an orientation meeting at the Operations and Statistical Centre in Kingston today! A full day of training and experience in cancer clinical trial conduct!
000
The Canadian Cancer Trials Group @cctg.bsky.social · 18/08/2026
Hear from #CCTG PR26 study chair Dr. Michael Ong as he discusses the TRIPLE-SWITCH trial, a phase III study exploring personalized treatment for patients with metastatic hormone-sensitive prostate cancer and a suboptimal PSA response. #ProstateCancer #ClinicalTrials buff.ly/dgklNxS
000
The Canadian Cancer Trials Group @cctg.bsky.social · 14/08/2026
The 2026 New Investigator Clinical Trials Course marks the 10th biennial offering of this #CCTG program! Since 2007, the NICTC has trained new Canadian investigators in the essentials of cancer clinical trial design and conduct. #ClinicalTrials buff.ly/ExLw6HZ
010
The Canadian Cancer Trials Group @cctg.bsky.social · 31/07/2026
Congratulations to Dr. Shivani Dadwal on enrolling her first patient to the #CCTG CRC.10 trial as a new investigator! A 2024–2025 CCTG New Investigator Practicum graduate, Dr. Dadwal is advancing more personalized treatment for patients with colon cancer. buff.ly/waBXgf6
000
The Canadian Cancer Trials Group @cctg.bsky.social · 29/07/2026
The #CCTG Quality of Life Committee is recruiting two new members with expertise or interest in patient-reported outcomes (PROs) in cancer clinical trials. Help advance patient-centered research in brain cancer or supportive care. Apply by August 31!#CancerResearch #ClinicalTrials buff.ly/cScBpnk
000
The Canadian Cancer Trials Group @cctg.bsky.social · 27/07/2026
On #WorldHeadAndNeckCancerDay, we're highlighting the #CCTG HN11 trial evaluating whether lymphatic mapping can help personalize radiotherapy for oropharyngeal cancer while reducing side effects and improving quality of life. #HeadAndNeckCancer #ClinicalTrials
000
The Canadian Cancer Trials Group @cctg.bsky.social · 24/07/2026
As Sarcoma Cancer Awareness Month comes to a close, we are highlighting #CCTG SR.7, a clinical trial for patients with high-risk retroperitoneal sarcoma studying whether chemotherapy before surgery can improve outcomes. #SarcomaAwareness
010
Reposted by The Canadian Cancer Trials Group
The Canadian Cancer Trials Group @cctg.bsky.social · 21/07/2026
#CCTG continues to advance cancer research across Canada with new trials now open and more on the horizon. From hematologic cancers to breast, lung, sarcoma, and supportive care, our clinical trial portfolio is helping shape the future of cancer care. #ClinicalTrials #CancerResearch
111
The Canadian Cancer Trials Group @cctg.bsky.social · 21/07/2026
#CCTG continues to advance cancer research across Canada with new trials now open and more on the horizon. From hematologic cancers to breast, lung, sarcoma, and supportive care, our clinical trial portfolio is helping shape the future of cancer care. #ClinicalTrials #CancerResearch
111
The Canadian Cancer Trials Group @cctg.bsky.social · 16/07/2026
A new #CCTG clinical trial, SC31 TEMPO, is now open! This study is evaluating an innovative online program designed to help people with prostate cancer and their caregivers better manage the physical and emotional challenges of cancer. #ProstateCancer #CancerResearch buff.ly/oj7LzVq
010
The Canadian Cancer Trials Group @cctg.bsky.social · 14/07/2026
During Sarcoma Cancer Awareness Month, we're highlighting #CCTG SRC.8, a clinical trial evaluating whether adding immunotherapy to chemotherapy can improve outcomes for patients with advanced sarcoma. #SarcomaAwarenessMonth #CureSarcoma
000
The Canadian Cancer Trials Group @cctg.bsky.social · 09/07/2026
Two new #CCTG cell therapy trials are now open in Canada! IND246 is evaluating the novel #CAR-T therapy #GCAR1 in solid cancers, while IND245 is exploring strategies to improve #CAR-T outcomes for patients with mantle cell lymphoma. #CellTherapy #CancerResearch
buff.ly
The first two CCTG led cell therapy trials are now open in Canada | Canadian Cancer Trials Group
CCTG is committed to the evaluation of innovative cell therapy products, strategies to improve cell therapy outcomes and to advancing accessibility for Canadian patients. IND246 study is a phase I…
010
The Canadian Cancer Trials Group @cctg.bsky.social · 06/07/2026
A new #CCTG clinical trial, LYC.2, has opened in Canada for patients with peripheral T-cell lymphoma (#PTCL)! This phase III study is evaluating whether high-dose chemotherapy followed by autologous stem cell transplant can reduce the risk of disease recurrence. #Lymphoma buff.ly/c8RMgOF
010
The Canadian Cancer Trials Group @cctg.bsky.social · 03/07/2026
#CCTG is seeking a volunteer #CRA representative to join the Hematology Disease Site Committee! This is an opportunity to contribute to the oversight and development of cancer clinical trials in Canada. Applications close July 15, 2026. #ClinicalResearch #Hematology buff.ly/kxVcaT7
021
The Canadian Cancer Trials Group @cctg.bsky.social · 28/06/2026
Today is Pride Day and #CCTG celebrates the strength, diversity, and contributions of 2SLGBTQIA+ communities. We remain committed to advancing inclusive cancer research and fostering environments where everyone feels seen, respected, and supported 🌈#PrideMonth #Pride2026
010
The Canadian Cancer Trials Group @cctg.bsky.social · 24/06/2026
The @cctg.bsky.social, @eortc.org, and @amrc-uk.bsky.social welcome the #G7 Leaders’ announcement recognizing cancer as a global priority and calling for stronger international cooperation to improve outcomes for patients: buff.ly/lvBpd0V
061
The Canadian Cancer Trials Group @cctg.bsky.social · 24/06/2026
Welcome Melanie Keats to #CCTG as the new Patient Representative for the Gynecology Disease Site Committee! Drawing on her experiences as a patient, caregiver, family member, and researcher, Melanie will ensure the patient voice remains central to cancer research. #PatientEngagment
010
The Canadian Cancer Trials Group @cctg.bsky.social · 22/06/2026
Join the next #CCTG CRA Lunch and Learn session on Compliance Tips and CAPA Tricks This Friday June 24th! These practical training sessions provide valuable insight and resources to support the activation and conduct of CCTG studies. Register now for this practical training session. buff.ly/GTSqkMc
000
The Canadian Cancer Trials Group @cctg.bsky.social · 21/06/2026
June 21 is National Indigenous Peoples Day. As part of CCTG’s commitment to reconciliation, we will continue to listen, learn, and identify how we can design clinical trials that are culturally safe and accessible for Indigenous peoples in Canada. #NIPD2026 #IndigenousPeoplesDay #CCTG
011
The Canadian Cancer Trials Group @cctg.bsky.social · 18/06/2026
The #CCTG Quality of Life committee is seeking two new network members with an interest in #PROs in cancer clinical trials. Opportunities are focused on brain cancer and supportive care. Join us in advancing patient-centered cancer research! buff.ly/4mr3nmV #CancerResearch #PatientReportedOutcomes
001
The Canadian Cancer Trials Group @cctg.bsky.social · 17/06/2026
#CCTG recognizes #CancerImmunotherapyMonth and the science transforming cancer treatment. A spotlight on the SRC8 trial, investigation if a combination of immunotherapy and chemotherapy is more effective than chemotherapy alone for adults with advanced sarcoma: buff.ly/FAA5dNE #Immune2Cancer
010
The Canadian Cancer Trials Group @cctg.bsky.social · 16/06/2026
This June #CCTG marks both National Indigenous History Month and Pride Month. It is a time to learn about and honour the diverse cultures, histories, and experiences of First Nations, Inuit, and Métis Peoples, and to celebrate the strength, resilience, and contributions of 2SLGBTQI+ communities.
000
The Canadian Cancer Trials Group @cctg.bsky.social · 15/06/2026
Applications are now open for the #CCTG 2026 New Investigator Training course (NITC)! This 2.5-day program equips Canadas next generation of cancer clinical trial investigators with the knowledge and skills needed to lead impactful research. #CancerResearch #ClinicalTrials buff.ly/Ij9U38k
010
The Canadian Cancer Trials Group @cctg.bsky.social · 11/06/2026
A new #myeloMATCH clinical trial, #CCTG ALC10 has opened in Canada! Exploring a new treatment option for older adults with acute myeloid leukemia #AML who may not be able to tolerate intensive chemotherapy. buff.ly/ABTpHbj #Hematology #ClinicalTrials #BCCancer @swog.org
a picture representing the recently opened #myeloMATCH clinical trial, #CCTG ALC10. Exploring a new treatment option for older adults with acute myeloid leukemia #AML who may not be able to tolerate intensive chemotherapy.
010
Reposted by The Canadian Cancer Trials Group
Vancouver Coastal Health Research Institute @vchresearch.bsky.social · 03/06/2026
A groundbreaking study led by VCHRI researcher Dr. Lucia Nappi identified a blood biomarker that could help doctors predict the early-stage germ cell cancer relapse & begin active treatment sooner: buff.ly/wLDl01S @cctg.bsky.social
ctg.queensu.ca
A simple blood test may detect tumor relapse in patients with early-stage germ cell tumors | Canadian Cancer Trials Group
The interim results of the GCC.1 / S1823 study were presented at ASCO 2026 during the Genitourinary Cancer Session. The study focuses on patients with early-stage germ cell tumors and the blood…
022
Reposted by The Canadian Cancer Trials Group
André Picard @picardonhealth @picardonhealth.bsky.social · 02/06/2026
This $3,000 supervised exercise program drastically cuts colon cancer recurrence. Here’s why Canadian doctors say it should be prescribed and funded like a drug, by Megan Ogilvie www.thestar.com/news/canada/... via @thestar.com
thestar.com
This $3,000 program drastically cuts colon cancer recurrence. Doctors say it should be funded like a drug
Supervised exercise programs, which cost about $3,000 per patient over three years, boost survival rates and save the health system money, study shows.
1208
The Canadian Cancer Trials Group @cctg.bsky.social · 02/06/2026
#CCTG HN.9 results presented at #ASCO26, highlighting the challenges of reducing treatment intensity while maintaining outcomes for patients with HPV-positive oropharyngeal cancer-investigating whether replacing the standard chemotherapy with immunotherapy could reduce side effects. buff.ly/bj30GIR
010
Reposted by The Canadian Cancer Trials Group
The Canadian Cancer Trials Group @cctg.bsky.social · 31/05/2026
A simple blood test may detect tumor relapse in patients with early-stage germ cell tumors. The interim results of the @swog.org S1823 (#CCTG GCC1) study presented at #ASCO26 could identify patients at higher risk of relapse earlier Presented by #DrLuciaNappi buff.ly/wLDl01S @vchresearch.bsky.social
022
The Canadian Cancer Trials Group @cctg.bsky.social · 01/06/2026
The #CCTG PR.21 secondary analysis presented at #ASCO26 explores treatment sequencing in advanced prostate cancer. Results support both therapies as treatment options and may help clinicians make more personalized treatment decisions based on patient preferences. buff.ly/DQLTfTB
000
The Canadian Cancer Trials Group @cctg.bsky.social · 01/06/2026
Landmark CO.21 CHALLENGE #ASCO26 economic analysis shows that exercise programs can reduce health system costs. Dr Chen leading #CCTG researchers showed that structured exercise has positive outcomes for patients and at a lower cost than most treatment regimens. buff.ly/xQTzQVY
000
The Canadian Cancer Trials Group @cctg.bsky.social · 31/05/2026
#CCTG at #ASCO2026 our Senior Investigator Dr Jonathan Loree is the discussant at the GI oral abstract session.
000
The Canadian Cancer Trials Group @cctg.bsky.social · 31/05/2026
A simple blood test may detect tumor relapse in patients with early-stage germ cell tumors. The interim results of the @swog.org S1823 (#CCTG GCC1) study presented at #ASCO26 could identify patients at higher risk of relapse earlier Presented by #DrLuciaNappi buff.ly/wLDl01S @vchresearch.bsky.social
022
The Canadian Cancer Trials Group @cctg.bsky.social · 31/05/2026
CO26 poster presentation at #ASCO2026 - Serum VEGF-A concentrations as a predictive biomarker of immunotherapy response in refractory metastatic colorectal cancer (mCRC): An exploratory analysis of CCTG CO.26 www.asco.org/abstracts-pr...
000
The Canadian Cancer Trials Group @cctg.bsky.social · 29/05/2026
The 2026 #ASCO Annual Meeting will be held in Chicago this weekend from May 29 through June 2 with a range of abstracts from #CCTG trials. Here is a list of the research that will be presented with abstract links - if you are attending make sure to stop by! #ASCO2026
000